Fernando Aranda Vega,
Pedro Berraondo,
Lorenzo Galluzzi
New Antibody Formats
Gebonden Engels 2022 9780323994026Levertijd ongeveer 9 werkdagen
Gratis verzonden
Samenvatting
New Antibody Formats, Volume 369 in the International Review of Cell and Molecular Biology serial, highlights new advances in the field with this new volume presenting interesting chapters on a variety of important topics, including Current innovative engineered antibodies, Advances in bispecific antibodies, Applications of trimerbodies for cancer immunotherapy, Multispecific mAb-Anticalin formats, New antibody formats to treat Lung Cancer, Immunocytokines: from bench to bedside, and Single domain antibodies in cancer.
Specificaties
Lezersrecensies
Wees de eerste die een lezersrecensie schrijft!
Inhoudsopgave
. Current innovative engineered antibodies
Jose Yelamos
2. Opportunities and challenges of bi-specific antibodies
Aina Segués, Shuyu Huang, Alice Sijts, Pedro Berraondo and Dietmar M. Zaiss
3. Applications of trimerbodies in cancer immunotherapy
Marta Compte, Laura Sanz and Luis Álvarez-Vallina
4. Anticalin®-based therapeutics: Expanding new frontiers in drug development
Aizea Morales-Kastresana, Martin Siegemund, Stefan Haak, Janet Peper-Gabriel, Vanessa Neiens and Christine Rothe
5. Overcoming the limitations of cytokines to improve cancer therapy
Claudia Augusta Di Trani, Assunta Cirella, Leire Arrizabalaga, Myriam Fernandez-Sendin, Angela Bella, Fernando Aranda, Ignacio Melero and Pedro Berraondo
6. Emerging applications of nanobodies in cancer therapy
Robin Maximilian Awad, Fien Meeus, Hannelore Ceuppens, Thomas Ertveldt, Heleen Hanssens, Quentin Lecocq, Lukasz Mateusiak, Katty Zeven, Hana Valenta, Timo W.M. De Groof, Yannick De Vlaeminck, Ahmet Krasniqi, Kim De Veirman, Cleo Goyvaerts, Matthias D’Huyvetter, Sophie Hernot, Nick Devoogdt and Karine Breckpot
Jose Yelamos
2. Opportunities and challenges of bi-specific antibodies
Aina Segués, Shuyu Huang, Alice Sijts, Pedro Berraondo and Dietmar M. Zaiss
3. Applications of trimerbodies in cancer immunotherapy
Marta Compte, Laura Sanz and Luis Álvarez-Vallina
4. Anticalin®-based therapeutics: Expanding new frontiers in drug development
Aizea Morales-Kastresana, Martin Siegemund, Stefan Haak, Janet Peper-Gabriel, Vanessa Neiens and Christine Rothe
5. Overcoming the limitations of cytokines to improve cancer therapy
Claudia Augusta Di Trani, Assunta Cirella, Leire Arrizabalaga, Myriam Fernandez-Sendin, Angela Bella, Fernando Aranda, Ignacio Melero and Pedro Berraondo
6. Emerging applications of nanobodies in cancer therapy
Robin Maximilian Awad, Fien Meeus, Hannelore Ceuppens, Thomas Ertveldt, Heleen Hanssens, Quentin Lecocq, Lukasz Mateusiak, Katty Zeven, Hana Valenta, Timo W.M. De Groof, Yannick De Vlaeminck, Ahmet Krasniqi, Kim De Veirman, Cleo Goyvaerts, Matthias D’Huyvetter, Sophie Hernot, Nick Devoogdt and Karine Breckpot
Rubrieken
- advisering
- algemeen management
- coaching en trainen
- communicatie en media
- economie
- financieel management
- inkoop en logistiek
- internet en social media
- it-management / ict
- juridisch
- leiderschap
- marketing
- mens en maatschappij
- non-profit
- ondernemen
- organisatiekunde
- personal finance
- personeelsmanagement
- persoonlijke effectiviteit
- projectmanagement
- psychologie
- reclame en verkoop
- strategisch management
- verandermanagement
- werk en loopbaan